Overview
The SLCO1B1 gene encodes the liver uptake gatekeeper OATP1B1. Unlike CYP liver enzymes that chemically modify drugs, SLCO1B1 sits on the hepatocyte bloodstream surface pulling cholesterol-lowering statins, bilirubin, and bile salts into the liver where statins actually work.
Its common reduced-function variant rs4149056 (*5) was catapulted to fame by the landmark SEARCH trial in the New England Journal of Medicine, proving a dramatic link between OATP1B1 transport defects and statin-induced muscle aches.
12p12.1 (Chromosome 12)
Detoxification & Cardiology PGx
Hepatic Uptake Transporter
Statin tolerance & muscle safety
Function of SLCO1B1 (OATP1B1)
When OATP1B1 transport slows down, oral statin (especially simvastatin acid) fails to enter hepatocytes cleanly, spilling into systemic blood where skeletal muscle tissue absorbs excess drug—triggering cramps, weakness, or CK elevation.
Key Aspects:
💪 Simvastatin Vulnerability (*5 / C)
A single C allele (T/C) raises simvastatin myopathy risk ~4.5-fold at high doses, while C/C homozygotes (~2–3% Europeans) reach ~16-fold higher odds.
💊 Smarter Statin Swaps Work
Hydrophilic statins like pravastatin or rosuvastatin (or lower-dose fluvastatin/pitavastatin) rely far less exclusively on SLCO1B1 alone, per CPIC guidelines.
🧬 Genetic Variants (SNPs)
Two neighboring coding variants resolve OATP1B1 star alleles (*1A, *1B, *5, and *15):
12:21178615
Primary Level 1A CPIC pharmacogenetic variant: disrupts surface OATP1B1 insertion, boosting systemic simvastatin acid exposure >200% in C/C carriers.
~15-18% (Europe)
12:21176804
Alone (*1B) has mild/neutral effects, but on the same chromosome as c.521T>C creates the reduced-transport *15 haplotype.
~40% (Europe)
Practical Significance
✅ Strategies & Guidance
- Discuss Statin Selection With Doctor: *5 carriers needing lipid lowering often tolerate rosuvastatin (5–20 mg) or pravastatin well under medical monitoring.
- Verify Thyroid & Vitamin D: Untreated hypothyroidism or severe vitamin D deficiency independently mimics statin myalgia.
- Watch Drug Interactions: Cyclosporine, gemfibrozil, and some antivirals inhibit OATP1B1 regardless of genetics.
⚠️ Clinical Notes & Risks
- Statin-Induced Myopathy & Rhabdomyolysis: Unexplained symmetrical thigh or shoulder aches on simvastatin/atorvastatin merit CK blood checks.
- Never Quit Lipid Therapy Unsupervised: Untreated high LDL/Lp(a) carries real cardiac risks—switch agents medically rather than stopping abruptly.
- Rotor Syndrome (Very Rare): Co-occurring complete loss of SLCO1B1 + SLCO1B3 elevates conjugated bilirubin benignly.
📚 Data Sources
- OMIM: #604843 (Solute Carrier Organic Anion Transporter 1B1)
- dbSNP: rs4149056 (*5), rs2306283 (*1B)
- CPIC Guideline: SLCO1B1, ABCG2, CYP2C9 and Statin-Associated Musculoskeletal Symptoms
- NEJM (SEARCH Group): SLCO1B1 variants and statin-induced myopathy
Last Update: November 2026
Related Research Guides for SLCO1B1
Related Genes in Detoxification
NAT2
NAT2 drives Phase II liver acetylation of drugs (isoniazid, sulfonamides) and heterocyclic amines. Variants divide individuals…
SOD2
SOD2 protects mitochondria from oxidative damage by neutralizing superoxide radicals....
UGT1A1
UGT1A1 glucuronidates bilirubin, hormones, and drugs such as irinotecan in the liver. Variants (*28, *6) cause…